P2Y(12) Receptor Blockade Augments Glycoprotein IIb‐IIIa Antagonist Inhibition of Platelet Activation, Aggregation, and Procoagulant Activity

BACKGROUND: New antiplatelet agents that provide greater, more consistent inhibition of the platelet ADP receptor P2Y(12) may be used in combination with glycoprotein (GP) IIb‐IIIa antagonists, but their combined effect on platelet function and procoagulant activity is not well studied. Therefore, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Berny‐Lang, Michelle A., Jakubowski, Joseph A., Sugidachi, Atsuhiro, Barnard, Marc R., Michelson, Alan D., Frelinger, Andrew L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698756/
https://www.ncbi.nlm.nih.gov/pubmed/23676293
http://dx.doi.org/10.1161/JAHA.113.000026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698756/
https://www.ncbi.nlm.nih.gov/pubmed/23676293
http://dx.doi.org/10.1161/JAHA.113.000026

Ejemplares similares